Context: As opposed to coronary heart disease (CHD) mortality, cardiovascular mortality attributed to non-CHD causes has increased.
pidemic overweightness and obesity is a global concern that is increasingly evident in childhood and adolescence, with reported prevalence of more than 30% in the United States and other developed countries (1) . There is solid evidence that adolescent overweightness and obesity are associated with deleterious cardiovascular outcomes in adulthood, predominantly coronary heart disease (CHD) (2) (3) (4) (5) and, to a lesser degree, stroke (5, 6) . However, less is known about whether the association with adolescent obesity exists for other non-CHD outcomes; as in most studies, cardiovascular death (dominated by fatal myocardial infarction) was analyzed as a single group. The need to assess other outcomes is supported by evidence that adolescent obesity is already associated with altered cardiac geometry and function (7) and by Mendelian randomization studies linking obesity with deep vein thrombosis in adults (8) . Notably, whereas CHD and stroke mortality of young adults (,50 years) have declined in most Western countries during the last two decades, non-CHD and nonstroke cardiovascular mortality has increased (9) . The latter, according to the Global Burden of Disease, increased among young adults between 1990 and 2015 in many developed countries such as the United States, the United Kingdom, and Israel, with annual increases of 0.5%, 1.2%, and 2.4%, respectively, whereas CHD mortality declined by 1.1%, 2.8%, and 4.7%, respectively (9) .
Most reports on the association between adolescent overweightness and future cardiovascular outcomes used conventional definitions of abnormally excessive weight and usually referred to the entire conventional normal range as a single reference group (3, (10) (11) (12) (13) . There is, however, evidence that childhood and adolescent body mass index (BMI) within the traditionally accepted normal range is associated with CHD morbidity and mortality (2, 4) . We recently demonstrated that mortality attributed to CHD, stroke, and sudden death in midlife was associated with BMI higher than 20 kg/m 2 at age 17 (5) . Our objective in this report was to assess the association between adolescent BMI and death attributed to fatal arrhythmias, hypertensive heart disease, cardiomyopathies, arterial disease (dominated by aortic aneurysms), heart failure, and pulmonary embolism.
Materials and Methods

Study population
All Israeli adolescents who are eligible for obligatory military service (Jewish, Druze, and Circassian males and nonorthodox Jewish females) are called up for a medical evaluation around the age of 17 years. The study sample comprised all Israeli adolescents (N = 2,454,693) who attended the medical examination at ages 16 to 19 years between 1 January 1967 and 31 December 2010 (Fig. 1) . Excluded from analysis were those with missing BMI (n = 64,186), non-Jewish minorities who were unrepresentative of their source population (n = 92,377), and those who died before 1981 (n = 3991), the year from which the underlying cause of death was available to us. The final sample comprised 2,294,139 participants (40.4% women). Orthodox and ultraorthodox Jewish women are not obligated to serve, may not be examined, and are underrepresented here, whereas the sample of Jewish men can be regarded as nationally representative at this age. Ethical approval for the study was provided by the Israel Defense Forces Medical Corps Institutional Review Board.
Primary outcomes and documentation of the cause of death
The primary outcomes of the study were deaths attributable to noncoronary nonstroke cardiovascular-specific outcomes, henceforth termed cardiovascular disease (CVD)-specific outcomes. These include fatal arrhythmias (cardiac arrest and ventricular fibrillation), hypertensive heart disease, cardiomyopathies, arterial disease, heart failure, and pulmonary embolism.
For sake of comparison, we also included in selected analyses data regarding CHD, stroke, and total CVD mortality. The underlying cause of death, as routinely officially coded from death notifications by the Israel Central Bureau of Statistics according to the International Classification of Diseases 9th and 10th revisions, was obtained by linkage using the participants' national ID number. The cause of death was available to us only from 1981 onward. The occurrence of death among recruits is documented in Israel Defense Forces records since 1967 with an indicator of service-related deaths (no other causes are provided). Follow-up ceased on the date of death from any cause, or 30 June 2011, whichever came first.
Data collection and study variables
The health examination was performed by military physicians who also reviewed the previous medical history. Standardized measurements of weight and height were conducted by trained personnel, with each participant barefoot and in underwear. BMI was calculated. Data regarding education, socioeconomic status (SES), country of birth, and country of origin were recorded. Education was grouped into #9, 10, 11, or 12 years of formal schooling. SES, based on locality of residence at the time of examination (14) , was grouped into low, medium, and high. Country of origin (classified by father's or grandfather's country of birth if the father was born abroad) and country of birth were grouped as reported previously (5) . In addition, we used a genetically influenced classification into Ashkenazi, Sephardi, and Eastern Jews (15) .
Malignancy and side effects of its therapy are predisposing factors to some of the outcomes, such as pulmonary embolism and cardiomyopathies. In addition, the incidence of certain cancers was also associated with adolescent overweightnesss and obesity in this cohort (16, 17) . We used data linkage with the national cancer registry (18) to identify incident cancers and assessed whether the association between BMI and the study outcomes is independent of cancer incidence.
Statistical analysis
BMI was treated as a continuous variable and was also grouped according to a modification of the World Health Organization (WHO) classification in which we subdivided the broad normal range, with the following subgroups: BMI , 18.5 kg/m 2 (underweight), 18.5 # BMI ,22.0 (low-normal), 22.0 # BMI , 25.0 (high-normal), 25.0 # BMI , 30.0 (overweight), and BMI $ 30 (obese). Because at age 17 adolescents have completed .98% of their growth (19) , the categorization by age-and sex-adjusted US Centers for Disease Control and Prevention (CDC) BMI percentiles (20) was conducted as a secondary analysis, with the following division: ,5th (underweight), 5th to 49th (low-normal), 50th to 84th (high-normal), 85th to 94th (overweight), and $95th (obese) (Supplemental Table 4 ). Person-year mortality rates were calculated with follow-up commencing from 1981. Kaplan-Meier survival curves were computed. Cox proportional hazard models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for CVD-specific outcomes, with the low-normal group as the reference category. Two main prespecified models were constructed as in a previous report (5) : an unadjusted and a multivariable model adjusted for age, sex, year of birth, residential SES, education, country of origin, and height. Although Keevil and Khaw have cautioned against inclusion of height and BMI in the same model (21) , inclusion or exclusion of height from our multivariable model had no effect on the coefficient for BMI. The assumption of proportionality of the hazards was visually confirmed for all variables.
Several sensitivity analyses were conducted. We restricted the Cox analysis to those with unimpaired medical status at baseline (i.e., no indication of any medical diagnosis in the prerecruitment medical evaluation that would limit combat service) to avert the possibility of reverse causality. We restricted the analysis to those enrolled in the study before 1981 to allow a minimum of three decades of follow-up. We stratified the analysis by sex. We also restricted the analysis to those that were free of cancer during the study follow-up to avert the possibility that the association between adolescent BMI and CVD-specific outcomes may be affected by cancer incidence, particularly that occurring early after examination. Multiple imputation was applied to those with missing data (1.4% of examinees) as reported previously (5). Analyses were performed using SPSS (version 23.0). Table 1 summarizes the main characteristics of study participants. The mean age at enrolment was 17.3 6 0.4, with more than 85% of participants being assessed between age 17 and 18. Although 85% of the adolescents were born in Israel, significant heterogeneity in their origins was observed, reflecting the diversity of the worldwide Jewish immigration to Israel. Most participants (80%) had a full school education. Lower SES was more prevalent among obese adolescents.
Results
Between 1981 and 2011, during 42,297,007 personyears of follow-up, 32,127 deaths were recorded in the cohort. Of these, the underlying cause of death of 3178 was attributed to CVD, including 279 cardiac arrest and ventricular fibrillation, 122 hypertensive heart disease, 121 cardiomyopathies, 114 arterial disease (of which 50 were classified as aortic aneurysm), 94 heart failure, and 70 resulting from pulmonary embolism. The median follow-up [18.4 years (interquartile range: 9.9 to 29.1)] was lower in the overweight and obese groups, reflecting the rise in prevalence of overweightness and obesity in recent years (22) . Table 2 delineates follow-up and crude person-year incidence rates across BMI groups. There was a close correspondence between the Kaplan-Meier and unadjusted Cox survival curves (Supplemental Fig. 1 ). When BMI was treated as a categorical variable, multivariable-adjusted Cox analyses showed a graded increase in risk generally commencing from the high-normal BMI category onwards for all outcomes (Table 2) . From the high-normal to the overweight to the obese categories, we recorded HRs of 1.4, 1.7, and 3.7 for arrhythmias; 1.9, 4.1, and 8.0 for hypertensive heart disease; 1.5, 2.4, and 4.0 for cardiomyopathies; 2.7, 5.0, and 3.5 for arterial disease; 1.7, 2.7, and 5.4 for heart failure; and 1.3, 1.8, and 3.0 for pulmonary embolism. Figure 2 shows the Cox survival functions of the study outcomes. All outcomes exhibited a significant trend in the association with BMI introduced as a continuous variable (P , 0.008; Supplemental Table 3) , with HRs ranging from 1.09 (95% CI: 1.03 to 1.16, P = 0.001) for arterial disease to 1.16 (95% CI: 1.11 to 1.21, P = 10
) for hypertensive heart disease for every 1 unit increment in BMI (Supplemental Table 3 ). There was an HR of 1.08 (95% CI: 1.00 to 1.18, P = 0.050) per unit BMI in an analysis of the 50 deaths attributed to aortic aneurysms (Supplemental Table 3 ). For comparison, stroke and total CVD exhibited HRs of 1.08 (95% CI: 1.05 to 1.10, P = 5.6 3 10 ) and 1.12 (95% CI: 1.11 to 1.13, P = 10 -116
). There was no evidence for interaction in the multivariable model predicting total CVDspecific mortality between BMI and any of the following: sex (P = 0.93), SES (P = 0.45), education level (P = 0.99), country of origin (P = 0.48), or country of birth (P = 0.36).
When BMI was grouped according to US CDC BMI percentiles, an increased multivariable-adjusted risk was already evident among the 50th to 85th percentile BMI group for all diagnoses when the 5th to 49th percentile group served as a reference. With the US CDC classification, overweightness was associated with HRs between 1.5 and 3.6 (P # 0.014) for death attributed to any of the primary outcomes. With the exception of Person-time incidence rate per 100,000 person-years of follow-up are shown. The association was assessed with Cox models adjusted for age, sex, birth year, residential SES, education, country of origin, and height. For all outcomes, there was a significant trend across the BMI categories (P # 0.001).
Abbreviation: SD, standard deviation. a Total cardiovascular mortality includes all cardiovascular diagnoses according to ICD coding (ICD-9: 390 to 459; ICD-10: I00 to I99). Tables 1-4) . A sex-specific analysis Figure 2 . The relationship between BMI at adolescence and cause-specific CVD survival. Multivariable Cox survival functions by BMI groupings are shown for mortality attributed to fatal arrhythmias (cardiac arrest and ventricular fibrillation), hypertensive heart disease, cardiomyopathies, arterial disease-related mortality, heart failure, and pulmonary embolism. Models were adjusted for sex, age, birth year, education, SES, country of origin, and height. VF, ventricular fibrillation.
(Supplemental Table 3 ) showed the association to be generally consistent in both sexes, with the exception of hypertensive heart disease, which was strongly associated with adolescent BMI in men but showed no association in women (HR men = 1.16, 95% CI: 1.12 to 1.22, P = 3.3 3 10 -11 vs HR women = 0.96, 95% CI: 0.78 to 1.18, P = 0.67, P value for interaction = 0.07). A series of sensitivity analyses was conducted. When we limited the analysis to those with unimpaired health (Supplemental Table 2 ), the risk associated with overweightness and obesity persisted for all outcomes and was accentuated for pulmonary embolism and heart failure. In this analysis, the borderline risk seen among the underweight for death attributed to heart failure (HR = 2.4, 95% CI: 0.9 to 3.2, P = 0.086) was ablated (HR = 1.4, 95% CI: 0.6 to 3.6, P = 0.44). Results persisted when the cohort was limited to those enrolled in the study up to 1980 (Supplemental Table 5 ), when the follow-up in the Cox models commenced from 1967 (Supplemental Table 6 ) or when the cohort was limited to those that were free of cancer during the follow-up period (Supplemental Table 7 ). We also analyzed the association for periods of 10 and 20 years of follow-up during which 112 and 370 CVD-specific deaths occurred, respectively, out of 800 of the entire follow-up period ( Table 3 ). The magnitude of the association increased with duration of follow-up. By 10 years' follow-up, obesity was associated with a borderline significant elevated risk, whereas after 20 years, the HRs were 1.4, 1.8, and 3.5 for the high-normal, overweight, and obese categories (all statistically significant), and for the entire follow-up period, the HRs increased to 1.5, 2.4, and 4.3, respectively. Findings also persisted when the country of origin was grouped according to Ashkenazi, Sephardi, and Eastern Jews (Supplemental Table 8 ).
Discussion
In this nationwide cohort with a follow-up extending up to 45 years, we report on the association between BMI in late adolescence and various CVD-specific mortality outcomes by mid-adulthood. The main findings are that BMI was consistently associated with all outcomes, with HRs ranging from 1.09 to 1.16 per unit increment in BMI and a graded increase in mortality from BMIs of 22.0 to 24.99 kg/m 2 onward. We previously showed for this cohort that the accepted normal range (i.e., 18.5 # BMI , 25.0) may conceal and underestimate the actual mortality risk associated with obesity (5). Adolescent overweightness (as defined by US CDC criteria) was associated with a twofold or greater risk of death attributed to the study outcomes. Findings were generally consistent between the sexes. Overall, these results withstood restriction of the analysis to those classified in good health status at baseline, being cancer-free throughout follow-up period, and sensitivity analysis regarding the follow-up duration.
Most studies reported in the literature relate to the association between adult obesity and the common cardiovascular outcomes, including CHD (23, 24) and stroke (24) , which constituted the majority of CVD deaths in the current cohort. Investigations regarding less common CVD-specific mortality outcomes, such as those studied here, which comprised 25% of all CVD deaths, are rare and were reported only for a small fraction of the outcomes (25) .
The association between childhood and adolescent obesity and future cardiovascular outcomes may be the result of unfavorable cardiac remodeling (7) and structural as well as functional changes in the arterial wall (26) (27) (28) . Several studies (29) (30) (31) have demonstrated increased left ventricular mass, an independent risk factor for cardiovascular morbidity and mortality (32) , in obese children and adolescents compared with controls of normal weight. Other studies have shown an association between childhood BMI and left atrial size (33, 34) , which is independently associated with a higher risk of atrial fibrillation, stroke, heart failure, and death in adults (35) . Furthermore, consistent with our findings regarding 
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The association was tested for follow-up intervals of 10, 20, and 31 (full period) years, for which 112, 370, and 800 deaths occurred. All models were multivariable adjusted (age, sex, birth year, country of origin, education, SES, and height).
doi: 10.1210/jc.2017-00329 https://academic.oup.com/jcemincreased mortality from cardiac arrhythmias in relation to higher BMIs, childhood obesity has been associated with lengthening of the QT interval (36) . Finally, evidence from a selective subsample of this cohort (2) and non-Israeli populations (37) supports the view that adolescent obesity is associated with deleterious cardiovascular outcomes, independent of adult BMI.
Of the CVD-specific outcomes, hypertensive mortality showed the strongest association with adolescent BMI, with a HR of 1.16 per unit increment in BMI, a strong graded increase in risk from the high-normal range, and an eightfold higher risk among obese adolescents. In an earlier cross-sectional investigation from this cohort, each increase of 1 unit of BMI at age 17 was associated with an 11% increased risk for systolic blood pressure higher than 130 mm Hg (38) . Others have reported that increased BMI in childhood is a predictor of becoming hypertensive in early adulthood. The Bogalusa Heart Study reported that overweight adolescents were 8.5 times more likely than their leaner peers to have hypertension as young adults (39) . These previous studies emphasize the association of childhood and adolescent obesity with hypertensive disease in adulthood.
BMI in late adolescence was associated with an increased long-term risk of early heart failure in adulthood in a longitudinal study of 1.6 million Swedish men (25) , indicating an optimal BMI around 20 kg/m 2 , a HR of 6.5 for obese adolescents, and a 1.18 higher risk for every unit increment in BMI. These estimates are comparable to a HR of 5.4 for heart failure mortality in obese adolescents and a HR of 1.12 per unit BMI in our study. Adulthood obesity has also been acknowledged as a risk factor for venous thromboembolic events (40, 41) . In the Framingham Heart Study, obesity was associated with increased risk for venous thromboembolic events with a HR of 1.9 (95% CI: 1.4 to 2.5) (40). In our study, death attributed to pulmonary embolism was associated with an adjusted HR of 1.8 for overweight adolescents and 3.0 for obese adolescents (WHO categories). An association was reported in several studies between increased BMI or increased waist circumference and the presence of abdominal aortic aneurysm (42, 43) , although some studies suggest that obesity may be associated with a decrease in abdominal aortic aneurysm mortality (44, 45) . In our cohort, higher BMI in late adolescence was related to a higher risk of death attributed to arterial disease, including aortic aneurysms and peripheral vascular diseases.
Our study has certain limitations. First, we lack data regarding BMI in adulthood, which prevented us from examining the pathway by which adolescent obesity might affect cardiovascular-specific mortality, in particular whether the effect of adolescent BMI is independent of adult BMI. Adolescent BMI tracks into adulthood (with a correlation of 0.53 between ages 17 and 50 in a subsample of our cohort) (46) . Notably, the magnitude of the association increased with the duration of follow-up, suggesting that a more prolonged exposure to overweightness/obesity, which was already evident in adolescence, may be an important determinant of cardiovascular-specific outcomes, similarly to deaths attributed to CHD (5). Second, waist circumference, which reflects abdominal adiposity and is associated with mortality even after accounting for BMI (47), was not measured in our cohort. Nevertheless, BMI is a wellstudied measure that is currently recommended by the US Preventive Services Task Force as the screening measure of choice for childhood and adolescent obesity (9) . Third, we were unable to control for CVD risk factors such as smoking status and exercise that could affect baseline BMI. We note, however, that adjustment for smoking had no effect in previous studies (3, 48) . Fourth, the study was limited to the Jewish population, which is ethnically diverse, although genetically similar (15) . Nevertheless, the findings are likely to be generalizable to populations elsewhere. For example, we recently showed that the association between BMI and cardiovascular mortality that comprised coronary, stroke, and sudden death was consistent with a study of Danish children (4, 5) . Furthermore, proportional mortality attributable to CVD ranked identically to that in Swedish recruits followed for three decades (49) . Fifth, the categorization of country of origin was limited to paternal data, as mother's country of origin was not available in this cohort. Of note, however, a close correspondence between maternal and paternal country of origin, particularly in the earlier years of our cohort, which produced most of the cardiovascular deaths, has previously been reported (50) . Sixth, we were unable to censor participants who were enrolled in the study and emigrated later from Israel. Yet, this would affect outcomes only if obesity was strongly protective in this small group, a most unlikely circumstance. Finally, the data presented here are of a young cohort, which reflects only a fraction of the overall noncoronary nonstroke cardiovascular mortality that will manifest as this cohort ages. The strengths of the study include standardized measurement rather than recall of weight and height (51) , the large sample size, and the extensive and comprehensive follow-up, which provided sufficient power to assess mortality rates within narrower BMI subgroups and the nationwide representative sample of Jewish men (although less so among Jewish women).
In summary, BMI in late adolescence, even within the currently accepted normal range, whether defined by the WHO or the US CDC, is an important risk factor for CVD-specific mortality in early and mid-adulthood, in addition to that previously reported for CHD and stroke.
